​

HCA Healthcare (HCA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

HCA Stock Forecast

HCA Healthcare (HCA) stock forecast, based on 46 Wall Street analysts, predicts a 12-month average price target of $514.38, with a high of $598.00 and a low of $425.00. This represents a 4.71% increase from the last price of $491.23.

$250 $320 $390 $460 $530 $600 High: $598 Avg: $514.38 Low: $425 Last Closed Price: $491.23

HCA Stock Rating

HCA Healthcare stock's rating consensus is Buy, based on 46 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 30 Buy (65.22%), 14 Hold (30.43%), 2 Sell (4.35%), and 0 Strong Sell (0.00%).

Buy
Total 46 0 2 14 30 Strong Sell Sell Hold Buy Strong Buy

HCA Price Target Upside V Benchmarks

TypeNameUpside
StockHCA Healthcare4.71%
SectorHealthcare Stocks 15.45%
IndustryMedical Care Facilities Stocks23.46%

Price Target Trends

1M3M12M
# Anlaysts101132
Avg Price Target$534.00$532.73$490.53
Last Closing Price$491.23$491.23$491.23
Upside/Downside8.71%8.45%-0.14%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 2621381125
Dec, 2511391-24
Nov, 251139-124
Oct, 2521210-125
Sep, 2521210-125
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 28, 2026RBC Capital$555.00$483.1614.87%12.98%
Jan 28, 2026KeyBanc$503.00$483.763.98%2.40%
Jan 28, 2026UBS$598.00$487.5322.66%21.74%
Jan 28, 2026Oppenheimer$540.00$505.846.75%9.93%
Jan 28, 2026UBS$588.00$505.8416.24%19.70%
Jan 28, 2026KeyBanc$550.00$505.848.73%11.96%
Jan 28, 2026Andrew MokBarclays$551.00$505.848.93%12.17%
Jan 22, 2026KeyBanc$500.00$465.447.43%1.79%
Jan 07, 2026Stephen BaxterWells Fargo$452.00$483.60-6.53%-7.99%
Jan 06, 2026Bernstein$503.00$479.534.89%2.40%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 28, 2026RBC CapitalOutperformOutperformhold
Jan 28, 2026Cowen & Co.BuyBuyhold
Jan 28, 2026BernsteinMarket PerformMarket Performhold
Jan 28, 2026UBSBuyBuyhold
Jan 28, 2026OppenheimerOutperformOutperformhold
Jan 28, 2026Cantor FitzgeraldOverweightOverweighthold
Jan 28, 2026BarclaysOverweightOverweighthold
Jan 27, 2026Bank of America SecuritiesNeutralNeutralhold
Jan 22, 2026KeyBancOverweightOverweighthold
Jan 06, 2026BernsteinMarket PerformMarket Performhold

Financial Forecast

EPS Forecast

$0 $7 $14 $21 $28 $35 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$21.51$19.44$19.24$0.08---
Avg Forecast$17.85$17.01$18.20$21.94$24.84$27.96$31.30
High Forecast$18.16$17.35$18.50$22.15$25.34$29.09$32.50
Low Forecast$17.65$16.82$18.04$21.82$24.06$27.03$30.19
Surprise %20.50%14.29%5.71%-99.64%---

Revenue Forecast

$55B $61B $67B $73B $79B $85B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$58.75B$60.23B$64.97B$70.60B---
Avg Forecast$59.02B$60.35B$64.15B$70.57B$74.57B$78.43B$82.55B
High Forecast$59.82B$61.26B$64.42B$70.75B$75.20B$79.95B$82.68B
Low Forecast$58.53B$59.82B$63.95B$70.43B$73.83B$77.42B$82.43B
Surprise %-0.46%-0.19%1.27%0.05%---

Net Income Forecast

$0 $2B $4B $5B $7B $9B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$6.96B$5.64B$5.24B$21.96M---
Avg Forecast$5.84B$6.56B$5.24B$5.76B$6.47B$7.35B$8.21B
High Forecast$7.01B$7.87B$6.29B$5.80B$6.63B$7.61B$8.51B
Low Forecast$4.68B$5.25B$4.19B$5.71B$6.30B$7.08B$7.90B
Surprise %19.01%-14.00%--99.62%---

HCA Forecast FAQ

Is HCA Healthcare stock a buy?

HCA Healthcare stock has a consensus rating of Buy, based on 46 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 30 Buy, 14 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that HCA Healthcare is a favorable investment for most analysts.

What is HCA Healthcare's price target?

HCA Healthcare's price target, set by 46 Wall Street analysts, averages $514.38 over the next 12 months. The price target range spans from $425 at the low end to $598 at the high end, suggesting a potential 4.71% change from the previous closing price of $491.23.

How does HCA Healthcare stock forecast compare to its benchmarks?

HCA Healthcare's stock forecast shows a 4.71% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical care facilities stocks industry (23.46%).

What is the breakdown of analyst ratings for HCA Healthcare over the past three months?

  • January 2026: 8.00% Strong Buy, 52.00% Buy, 32.00% Hold, 4.00% Sell, 4.00% Strong Sell.
  • December 2025: 4.17% Strong Buy, 54.17% Buy, 37.50% Hold, 4.17% Sell, 0% Strong Sell.
  • November 2025: 4.17% Strong Buy, 54.17% Buy, 37.50% Hold, 0% Sell, 4.17% Strong Sell.

What is HCA Healthcare’s EPS forecast?

HCA Healthcare's average annual EPS forecast for its fiscal year ending in December 2025 is $24.84, marking a 30950.00% increase from the reported $0.08 in 2024. Estimates for the following years are $27.96 in 2026, and $31.3 in 2027.

What is HCA Healthcare’s revenue forecast?

HCA Healthcare's average annual revenue forecast for its fiscal year ending in December 2025 is $74.57B, reflecting a 5.61% increase from the reported $70.6B in 2024. The forecast for 2026 is $78.43B, and $82.55B for 2027.

What is HCA Healthcare’s net income forecast?

HCA Healthcare's net income forecast for the fiscal year ending in December 2025 stands at $6.47B, representing an 29342.21% increase from the reported $21.96M in 2024. Projections indicate $7.35B in 2026, and $8.21B in 2027.